Table of Content

1 Bio-protein Drug Market Overview
1.1 Bio-protein Drug Product Overview
1.2 Bio-protein Drug Market Segment by Type
1.2.1 Monoclonal Antibodies
1.2.2 Therapeutic Proteins
1.2.3 Vaccines
1.3 Global Bio-protein Drug Market Size by Type
1.3.1 Global Bio-protein Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Bio-protein Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Bio-protein Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bio-protein Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Bio-protein Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Bio-protein Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Bio-protein Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Bio-protein Drug Sales Breakdown by Type (2018-2024)
2 Global Bio-protein Drug Market Competition by Company
2.1 Global Top Players by Bio-protein Drug Sales (2018-2024)
2.2 Global Top Players by Bio-protein Drug Revenue (2018-2024)
2.3 Global Top Players by Bio-protein Drug Price (2018-2024)
2.4 Global Top Manufacturers Bio-protein Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bio-protein Drug Market Competitive Situation and Trends
2.5.1 Bio-protein Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Bio-protein Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-protein Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Bio-protein Drug Market
2.8 Key Manufacturers Bio-protein Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bio-protein Drug Status and Outlook by Region
3.1 Global Bio-protein Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Bio-protein Drug Historic Market Size by Region
3.2.1 Global Bio-protein Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Bio-protein Drug Sales in Value by Region (2018-2024)
3.2.3 Global Bio-protein Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Bio-protein Drug Forecasted Market Size by Region
3.3.1 Global Bio-protein Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Bio-protein Drug Sales in Value by Region (2024-2034)
3.3.3 Global Bio-protein Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Bio-protein Drug by Application
4.1 Bio-protein Drug Market Segment by Application
4.1.1 Pharma and Biotech Companies
4.1.2 CROs
4.1.3 Academics
4.2 Global Bio-protein Drug Market Size by Application
4.2.1 Global Bio-protein Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Bio-protein Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Bio-protein Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bio-protein Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Bio-protein Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Bio-protein Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Bio-protein Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Bio-protein Drug Sales Breakdown by Application (2018-2024)
5 North America Bio-protein Drug by Country
5.1 North America Bio-protein Drug Historic Market Size by Country
5.1.1 North America Bio-protein Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Bio-protein Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Bio-protein Drug Sales in Value by Country (2018-2024)
5.2 North America Bio-protein Drug Forecasted Market Size by Country
5.2.1 North America Bio-protein Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Bio-protein Drug Sales in Value by Country (2024-2034)
6 Europe Bio-protein Drug by Country
6.1 Europe Bio-protein Drug Historic Market Size by Country
6.1.1 Europe Bio-protein Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Bio-protein Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Bio-protein Drug Sales in Value by Country (2018-2024)
6.2 Europe Bio-protein Drug Forecasted Market Size by Country
6.2.1 Europe Bio-protein Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Bio-protein Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Bio-protein Drug by Region
7.1 Asia-Pacific Bio-protein Drug Historic Market Size by Region
7.1.1 Asia-Pacific Bio-protein Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Bio-protein Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Bio-protein Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Bio-protein Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Bio-protein Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Bio-protein Drug Sales in Value by Region (2024-2034)
8 Latin America Bio-protein Drug by Country
8.1 Latin America Bio-protein Drug Historic Market Size by Country
8.1.1 Latin America Bio-protein Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Bio-protein Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Bio-protein Drug Sales in Value by Country (2018-2024)
8.2 Latin America Bio-protein Drug Forecasted Market Size by Country
8.2.1 Latin America Bio-protein Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Bio-protein Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Bio-protein Drug by Country
9.1 Middle East and Africa Bio-protein Drug Historic Market Size by Country
9.1.1 Middle East and Africa Bio-protein Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Bio-protein Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Bio-protein Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Bio-protein Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Bio-protein Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Bio-protein Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Abbott Laboratories Bio-protein Drug Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Bayer AG
10.2.1 Bayer AG Company Information
10.2.2 Bayer AG Introduction and Business Overview
10.2.3 Bayer AG Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bayer AG Bio-protein Drug Products Offered
10.2.5 Bayer AG Recent Development
10.3 Eli Lilly and Company
10.3.1 Eli Lilly and Company Company Information
10.3.2 Eli Lilly and Company Introduction and Business Overview
10.3.3 Eli Lilly and Company Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Eli Lilly and Company Bio-protein Drug Products Offered
10.3.5 Eli Lilly and Company Recent Development
10.4 Amgen Inc.
10.4.1 Amgen Inc. Company Information
10.4.2 Amgen Inc. Introduction and Business Overview
10.4.3 Amgen Inc. Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Amgen Inc. Bio-protein Drug Products Offered
10.4.5 Amgen Inc. Recent Development
10.5 Biocon Ltd.
10.5.1 Biocon Ltd. Company Information
10.5.2 Biocon Ltd. Introduction and Business Overview
10.5.3 Biocon Ltd. Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Biocon Ltd. Bio-protein Drug Products Offered
10.5.5 Biocon Ltd. Recent Development
10.6 Dr. Reddy’s Laboratories
10.6.1 Dr. Reddy’s Laboratories Company Information
10.6.2 Dr. Reddy’s Laboratories Introduction and Business Overview
10.6.3 Dr. Reddy’s Laboratories Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Dr. Reddy’s Laboratories Bio-protein Drug Products Offered
10.6.5 Dr. Reddy’s Laboratories Recent Development
10.7 Roche
10.7.1 Roche Company Information
10.7.2 Roche Introduction and Business Overview
10.7.3 Roche Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Roche Bio-protein Drug Products Offered
10.7.5 Roche Recent Development
10.8 Fresenius kabi
10.8.1 Fresenius kabi Company Information
10.8.2 Fresenius kabi Introduction and Business Overview
10.8.3 Fresenius kabi Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Fresenius kabi Bio-protein Drug Products Offered
10.8.5 Fresenius kabi Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Company Information
10.9.2 GlaxoSmithKline Introduction and Business Overview
10.9.3 GlaxoSmithKline Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 GlaxoSmithKline Bio-protein Drug Products Offered
10.9.5 GlaxoSmithKline Recent Development
10.10 Johnson & Johnson
10.10.1 Johnson & Johnson Company Information
10.10.2 Johnson & Johnson Introduction and Business Overview
10.10.3 Johnson & Johnson Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Johnson & Johnson Bio-protein Drug Products Offered
10.10.5 Johnson & Johnson Recent Development
10.11 Merck
10.11.1 Merck Company Information
10.11.2 Merck Introduction and Business Overview
10.11.3 Merck Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Merck Bio-protein Drug Products Offered
10.11.5 Merck Recent Development
10.12 Novartis AG
10.12.1 Novartis AG Company Information
10.12.2 Novartis AG Introduction and Business Overview
10.12.3 Novartis AG Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Novartis AG Bio-protein Drug Products Offered
10.12.5 Novartis AG Recent Development
10.13 Panacea Biotec
10.13.1 Panacea Biotec Company Information
10.13.2 Panacea Biotec Introduction and Business Overview
10.13.3 Panacea Biotec Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Panacea Biotec Bio-protein Drug Products Offered
10.13.5 Panacea Biotec Recent Development
10.14 ProBioGen AG
10.14.1 ProBioGen AG Company Information
10.14.2 ProBioGen AG Introduction and Business Overview
10.14.3 ProBioGen AG Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 ProBioGen AG Bio-protein Drug Products Offered
10.14.5 ProBioGen AG Recent Development
10.15 Sanofi
10.15.1 Sanofi Company Information
10.15.2 Sanofi Introduction and Business Overview
10.15.3 Sanofi Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Sanofi Bio-protein Drug Products Offered
10.15.5 Sanofi Recent Development
10.16 Reliance Life Science Pvt. Ltd.
10.16.1 Reliance Life Science Pvt. Ltd. Company Information
10.16.2 Reliance Life Science Pvt. Ltd. Introduction and Business Overview
10.16.3 Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Reliance Life Science Pvt. Ltd. Bio-protein Drug Products Offered
10.16.5 Reliance Life Science Pvt. Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bio-protein Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bio-protein Drug Industrial Chain Analysis
11.4 Bio-protein Drug Market Dynamics
11.4.1 Bio-protein Drug Industry Trends
11.4.2 Bio-protein Drug Market Drivers
11.4.3 Bio-protein Drug Market Challenges
11.4.4 Bio-protein Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bio-protein Drug Distributors
12.3 Bio-protein Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal Antibodies
Table 2. Major Company of Therapeutic Proteins
Table 3. Major Company of Vaccines
Table 4. Global Bio-protein Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Bio-protein Drug Sales by Type (2018-2024) & (K Units)
Table 6. Global Bio-protein Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Bio-protein Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Bio-protein Drug Market Share in Value by Type (2018-2024)
Table 9. Global Bio-protein Drug Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Bio-protein Drug Sales by Type (2024-2034) & (K Units)
Table 11. Global Bio-protein Drug Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Bio-protein Drug Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Bio-protein Drug Sales Market Share in Value by Type (2024-2034)
Table 14. Global Bio-protein Drug Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Bio-protein Drug Sales by Type (2018-2024) & (K Units)
Table 16. North America Bio-protein Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Bio-protein Drug Sales (K Units) by Type (2018-2024)
Table 18. Europe Bio-protein Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Bio-protein Drug Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Bio-protein Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Bio-protein Drug Sales (K Units) by Type (2018-2024)
Table 22. Latin America Bio-protein Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Bio-protein Drug Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Bio-protein Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Bio-protein Drug Sales by Company (2018-2024) & (K Units)
Table 26. Global Bio-protein Drug Sales Share by Company (2018-2024)
Table 27. Global Bio-protein Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Bio-protein Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Bio-protein Drug Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Bio-protein Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Bio-protein Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-protein Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Bio-protein Drug Market
Table 34. Key Manufacturers Bio-protein Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Bio-protein Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Bio-protein Drug Sales by Region (2018-2024) & (K Units)
Table 38. Global Bio-protein Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Bio-protein Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Bio-protein Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Bio-protein Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Bio-protein Drug Sales by Region (2024-2034) & (K Units)
Table 43. Global Bio-protein Drug Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Bio-protein Drug Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Bio-protein Drug Sales Market Share in Value by Region (2024-2034)
Table 46. Global Bio-protein Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Bio-protein Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Bio-protein Drug Sales by Application (2018-2024) & (K Units)
Table 49. Global Bio-protein Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Bio-protein Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Bio-protein Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Bio-protein Drug Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Bio-protein Drug Sales by Application (2024-2034) & (K Units)
Table 54. Global Bio-protein Drug Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Bio-protein Drug Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Bio-protein Drug Sales Market Share in Value by Application (2024-2034)
Table 57. Global Bio-protein Drug Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Bio-protein Drug Sales by Application (2018-2024) (K Units)
Table 59. North America Bio-protein Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Bio-protein Drug Sales by Application (2018-2024) (K Units)
Table 61. Europe Bio-protein Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Bio-protein Drug Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Bio-protein Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Bio-protein Drug Sales by Application (2018-2024) (K Units)
Table 65. Latin America Bio-protein Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Bio-protein Drug Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Bio-protein Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Bio-protein Drug Sales by Country (2018-2024) & (K Units)
Table 69. North America Bio-protein Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Bio-protein Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Bio-protein Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Bio-protein Drug Sales by Country (2024-2034) & (K Units)
Table 73. North America Bio-protein Drug Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Bio-protein Drug Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Bio-protein Drug Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Bio-protein Drug Sales by Country (2018-2024) & (K Units)
Table 77. Europe Bio-protein Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Bio-protein Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Bio-protein Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Bio-protein Drug Sales by Country (2024-2034) & (K Units)
Table 81. Europe Bio-protein Drug Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Bio-protein Drug Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Bio-protein Drug Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Bio-protein Drug Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Bio-protein Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Bio-protein Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Bio-protein Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Bio-protein Drug Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Bio-protein Drug Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Bio-protein Drug Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Bio-protein Drug Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Bio-protein Drug Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Bio-protein Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Bio-protein Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Bio-protein Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Bio-protein Drug Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Bio-protein Drug Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Bio-protein Drug Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Bio-protein Drug Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Bio-protein Drug Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Bio-protein Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Bio-protein Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Bio-protein Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Bio-protein Drug Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Bio-protein Drug Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Bio-protein Drug Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Bio-protein Drug Sales Market Share in Value by Country (2024-2034)
Table 108. Abbott Laboratories Company Information
Table 109. Abbott Laboratories Introduction and Business Overview
Table 110. Abbott Laboratories Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Abbott Laboratories Bio-protein Drug Product
Table 112. Abbott Laboratories Recent Development
Table 113. Bayer AG Company Information
Table 114. Bayer AG Introduction and Business Overview
Table 115. Bayer AG Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Bayer AG Bio-protein Drug Product
Table 117. Bayer AG Recent Development
Table 118. Eli Lilly and Company Company Information
Table 119. Eli Lilly and Company Introduction and Business Overview
Table 120. Eli Lilly and Company Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Eli Lilly and Company Bio-protein Drug Product
Table 122. Eli Lilly and Company Recent Development
Table 123. Amgen Inc. Company Information
Table 124. Amgen Inc. Introduction and Business Overview
Table 125. Amgen Inc. Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Amgen Inc. Bio-protein Drug Product
Table 127. Amgen Inc. Recent Development
Table 128. Biocon Ltd. Company Information
Table 129. Biocon Ltd. Introduction and Business Overview
Table 130. Biocon Ltd. Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Biocon Ltd. Bio-protein Drug Product
Table 132. Biocon Ltd. Recent Development
Table 133. Dr. Reddy’s Laboratories Company Information
Table 134. Dr. Reddy’s Laboratories Introduction and Business Overview
Table 135. Dr. Reddy’s Laboratories Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Dr. Reddy’s Laboratories Bio-protein Drug Product
Table 137. Dr. Reddy’s Laboratories Recent Development
Table 138. Roche Company Information
Table 139. Roche Introduction and Business Overview
Table 140. Roche Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Roche Bio-protein Drug Product
Table 142. Roche Recent Development
Table 143. Fresenius kabi Company Information
Table 144. Fresenius kabi Introduction and Business Overview
Table 145. Fresenius kabi Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Fresenius kabi Bio-protein Drug Product
Table 147. Fresenius kabi Recent Development
Table 148. GlaxoSmithKline Company Information
Table 149. GlaxoSmithKline Introduction and Business Overview
Table 150. GlaxoSmithKline Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. GlaxoSmithKline Bio-protein Drug Product
Table 152. GlaxoSmithKline Recent Development
Table 153. Johnson & Johnson Company Information
Table 154. Johnson & Johnson Introduction and Business Overview
Table 155. Johnson & Johnson Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Johnson & Johnson Bio-protein Drug Product
Table 157. Johnson & Johnson Recent Development
Table 158. Merck Company Information
Table 159. Merck Introduction and Business Overview
Table 160. Merck Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Merck Bio-protein Drug Product
Table 162. Merck Recent Development
Table 163. Novartis AG Company Information
Table 164. Novartis AG Introduction and Business Overview
Table 165. Novartis AG Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Novartis AG Bio-protein Drug Product
Table 167. Novartis AG Recent Development
Table 168. Panacea Biotec Company Information
Table 169. Panacea Biotec Introduction and Business Overview
Table 170. Panacea Biotec Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Panacea Biotec Bio-protein Drug Product
Table 172. Panacea Biotec Recent Development
Table 173. ProBioGen AG Company Information
Table 174. ProBioGen AG Introduction and Business Overview
Table 175. ProBioGen AG Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. ProBioGen AG Bio-protein Drug Product
Table 177. ProBioGen AG Recent Development
Table 178. Sanofi Company Information
Table 179. Sanofi Introduction and Business Overview
Table 180. Sanofi Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. Sanofi Bio-protein Drug Product
Table 182. Sanofi Recent Development
Table 183. Reliance Life Science Pvt. Ltd. Company Information
Table 184. Reliance Life Science Pvt. Ltd. Introduction and Business Overview
Table 185. Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Reliance Life Science Pvt. Ltd. Bio-protein Drug Product
Table 187. Reliance Life Science Pvt. Ltd. Recent Development
Table 188. Key Raw Materials Lists
Table 189. Raw Materials Key Suppliers Lists
Table 190. Bio-protein Drug Market Trends
Table 191. Bio-protein Drug Market Drivers
Table 192. Bio-protein Drug Market Challenges
Table 193. Bio-protein Drug Market Restraints
Table 194. Bio-protein Drug Distributors List
Table 195. Bio-protein Drug Downstream Customers
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-protein Drug Product Picture
Figure 2. Global Bio-protein Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Bio-protein Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Bio-protein Drug Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Monoclonal Antibodies
Figure 6. Global Monoclonal Antibodies Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Therapeutic Proteins
Figure 8. Global Therapeutic Proteins Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Vaccines
Figure 10. Global Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Bio-protein Drug Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Bio-protein Drug Sales Market Share by Type in 2022 & 2034
Figure 13. North America Bio-protein Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Bio-protein Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Bio-protein Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Bio-protein Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Bio-protein Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Bio-protein Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Bio-protein Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Bio-protein Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Bio-protein Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Bio-protein Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Bio-protein Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Bio-protein Drug Revenue in 2022
Figure 25. Bio-protein Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Pharma and Biotech Companies
Figure 27. Global Pharma and Biotech Companies Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of CROs
Figure 29. Global CROs Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Academics
Figure 31. Global Academics Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Bio-protein Drug Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Bio-protein Drug Sales Market Share by Application in 2022 & 2034
Figure 34. North America Bio-protein Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Bio-protein Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Bio-protein Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Bio-protein Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Bio-protein Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Bio-protein Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Bio-protein Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Bio-protein Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Bio-protein Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Bio-protein Drug Manufacturing Cost Structure
Figure 45. Bio-protein Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed